nderstanding current childhood pneumonia management practices in a few selected low- and middle-income countries
Not Applicable
- Conditions
- Chest-indrawing pneumoniaRespiratory
- Registration Number
- ISRCTN12687253
- Lead Sponsor
- World Health Organization
- Brief Summary
2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38904143/ (added 21/06/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 2500
Inclusion Criteria
1. Age 2-59 months old
2. Living in a geographic area where follow-up for 15 days can be accomplished
3. Presenting to a first-level health facility with chest-indrawing pneumonia
Exclusion Criteria
1. Age <2 months or >5 years
2. Any general danger signs (convulsion, inability to drink or breastfeed, vomiting everything, lethargic/unconscious)
3. Stridor in a calm child
4. Oxygen saturation (SpO2) <90%
5. Currently included in any other study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival status of 2-59 month-old children with chest-indrawing pneumonia who presented at the primary health care facility in a programme setting measured using the information provided by the caregivers by day 15
- Secondary Outcome Measures
Name Time Method The management (including oral treatment, which one, for how many days, or hospitalisation, with injectable antibiotics, how many days, and treatment adherence) of children 2-59 months of age with chest-indrawing pneumonia presenting at the primary health care facility in a programme setting measured using the information provided by the caregiver, medical records, and the availability of medicines or any prescription at day 15